Research
Browse or search our latest peer-reviewed research publications.
Surrogate Endpoints Used in NICE Technology Appraisals for Oncology and Non-Oncology Indications, 2022–23
ISPOR Europe 2023: Poster Session: 1. 13 November 2023. Poster Session Time: 10:30-13:30. Discussion Period: 12:30-13:30.
The underestimated and overlooked burden of diarrhea and constipation in cancer patients
Moschen A, Yossi S, Marjenberg Z, Heptinstall A, Pooley N, Marczewska A. The underestimated and overlooked burden of diarrhea and constipation in cancer patients. Curr Oncol Rep 2022;24(7):861-874
Therapeutic benefit of orphan drugs in oncology: evidence at the point of European Marketing Authorisation
Odnoletkova I, Marjenberg Z, Pooley N, Langham S. Therapeutic benefit of orphan drugs in oncology: evidence at the point of European Marketing Authorisation. Value Health 2019;22(Suppl 3): S491
Health technology assessment of companion diagnostics alongside therapeutic agents in oncology: experience of the NICE technology appraisal programme
Langham S, Lewis J. Health technology assessment of companion diagnostics alongside therapeutic agents in oncology: experience of the NICE technology appraisal programme. Value Health 2018;21(Suppl 3):S272
Conducting and reporting indirect treatment comparisons: a critical appraisal of oncology technology appraisals
Langham J, Langham S. Conducting and reporting indirect treatment comparisons: a critical appraisal of oncology technology appraisals. Value Health 2018;21(Suppl 3):S68